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The canonical Wnt signaling pathway is critical for development of the mammalian central
nervous system and regulates diverse processes throughout adulthood, including adult
neurogenesis. Glycogen synthase kinase-3 (GSK-3) antagonizes the canonical Wnt path-
way and therefore also plays a central role in neural development and adult neurogenesis.
Lithium, the ﬁrst line of therapy for bipolar disorder, inhibits GSK-3, activatesWnt signaling
and stimulates adult neurogenesis, which may be important for its therapeutic effects.
GSK-3 also regulates other critical signaling pathways which may contribute to the ther-
apeutic effects of lithium, including growth factor/neurotrophin signaling downstream of
Akt. Here we will review the roles of GSK-3 in CNS development and adult neurogenesis,
with a focus on the canonical Wnt pathway. We will also discuss the validation of GSK-3
as the relevant target of lithium and the mechanisms downstream of GSK-3 that inﬂuence
mammalian behavior.
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INTRODUCTION
Wnt signaling is essential for patterning, cell fate speciﬁcation,
and stem cell regulation during the development of many tissues
and organs, including the mammalian brain (reviewed in Ciani
and Salinas, 2005; Petersen and Reddien, 2009; Kim and Snider,
2011). In adults, Wnt signals continue to inﬂuence the mainte-
nance and regeneration of many tissues by regulating stem cell
homeostasis and cell proliferation (reviewed in Gu et al., 2010;
Wend et al., 2010; Yeung et al., 2011). In the adult brain, Wnt sig-
naling also regulates critical processes such as neurite outgrowth,
axon remodeling, synapse formation and plasticity, and neuroge-
nesis (reviewed in Ciani and Salinas, 2005; Budnik and Salinas,
2011). In the canonical Wnt pathway, Wnts inhibit glycogen syn-
thase kinase-3 (GSK-3) to activate downstream signaling. Lithium,
which has been used to treat bipolar disorder (BPD) for decades,
inhibits GSK-3 both directly and indirectly, raising the possibility
that the therapeutic effects of lithium may involve activation of
downstream Wnt signaling (reviewed in MacDonald et al., 2009;
O’Brien and Klein, 2009). However, GSK-3 also regulates other
pathways – distinct from the canonical Wnt pathway – that are
involved in neuronal development and function, and these may
also play important roles in the response to lithium. As these path-
ways are discussed in detail elsewhere in this volume (reviewed in
Kaidanovich-Beilin and Woodgett, 2011; Kim and Snider, 2011),
this review will focus on GSK-3 and canonical Wnt signaling in
CNS development, adult neurogenesis, and BPD.
GSK-3 IS A CRITICAL REGULATOR OF DIVERSE SIGNALING
PATHWAYS
Glycogen synthase kinase-3 constitutively antagonizes the canon-
ical Wnt signaling pathway and must be inhibited for the pathway
to function (Figure 1). In the absence of Wnt ligands, GSK-3, the
transcriptional co-activator β-catenin, and the tumor suppressor
adenomatous polyposis coli (APC) bind directly to the scaffold-
ing protein Axin in a complex that facilitates phosphorylation
of β-catenin by GSK-3, which targets β-catenin for proteasome-
dependent degradation. Wnt ligands bind to the receptor Friz-
zled, inducing phosphorylation of the essential co-receptors low
density lipoprotein receptor-related protein 5 (LRP5) and LRP6
which results in GSK-3 inhibition and β-catenin stabilization.
Stabilized β-catenin enters the nucleus and interacts with the
lymphocyte enhancer factor/T-cell factor (LEF/TCF) family of
transcription factors to activate transcription (reviewed inClevers,
2006; MacDonald et al., 2009; Wu and Pan, 2010).
In addition to its critical role in regulating Wnt signal-
ing, GSK-3 phosphorylates over 100 substrates and regulates
multiple signaling pathways, such as Sonic Hedgehog, Notch,
and growth factor signaling through Akt which inﬂuences cell
survival decisions in the brain (reviewed in Kockeritz et al.,
2006; Kaidanovich-Beilin and Woodgett, 2011; Kim and Snider,
2011). Insulin, neurotrophins, and other growth factors activate
phosphatidylinositol-3-kinase (PI3K) and Akt which phosphory-
lates GSK-3 at an N-terminal serine residue (Ser21 on the GSK-3α
isoform,Ser9 onGSK-3β; Cross et al., 1995;McManus et al., 2005).
This creates a pseudosubstrate motif that inhibits GSK-3 allow-
ing activation of downstream effectors such as Glycogen Synthase
and the mammalian target of rapamycin (mTOR; Dajani et al.,
2001; reviewed in Proud, 2006; Kim et al., 2011). Importantly,
GSK-3 in theWnt-responsive Axin complex is not regulated by N-
terminal serine phosphorylation, as neither insulin/Akt nor Wnt
ligands induce Ser9/21 phosphorylation of Axin-associatedGSK-3
(Ding et al., 2000; Ng et al., 2009). Additionally, Wnt signaling
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FIGURE 1 | Glycogen synthase kinase-3 regulatesWnt and
Akt-dependent signaling. Growth factors, including neurotrophins,
activate Akt, which phosphorylates, and inhibits GSK-3 allowing activation
of downstream effectors to promote cell survival. Both Akt and GSK-3 have
multiple targets not shown here for the sake of clarity. Wnts inhibit GSK-3
within the Axin complex stabilizing β-catenin, which activatesWnt target
genes, and promotes neurogenesis. Axin-associated GSK-3 is not regulated
by N-terminal phosphorylation and is thus distinct from Akt-regulated
GSK-3, and both pools are inhibited by lithium. Thus lithium may stimulate
neurogenesis by activatingWnt/β-catenin signaling and enhancing cell
survival.
is normal in double knockin mice in which the Gsk3aser21 and
Gsk3bser9 phosphorylation sites have been mutated to alanine,
further demonstrating that Wnt ligands inhibit GSK-3 by a mech-
anism other than Ser21/9 phosphorylation (Ding et al., 2000;
McManus et al., 2005). Therefore Wnt-responsive GSK-3 and
growth factor/Akt responsive GSK-3 represent distinct subcellular
pools regulated by distinct mechanisms.
CANONICAL Wnt SIGNALING DURING CENTRAL NERVOUS
SYSTEM DEVELOPMENT
Wnt signaling regulates numerous critical processes throughout
the development of the vertebrate central nervous system. These
include patterning and cell fate speciﬁcation, proliferation, and
neuronal morphology (Chenn and Walsh, 2002; Woodhead et al.,
2006; reviewed in Ciani and Salinas, 2005; Budnik and Salinas,
2011).
PATTERNING
In the early vertebrate embryo, Wnt signaling promotes poste-
rior development and suppresses anterior development of the
neural tube. Thus inhibition of Wnt signaling reduces posterior
development and expands anterior regions, whereas aberrantWnt
pathway activation enhances posterior and reduces anterior devel-
opment (reviewed inCiani and Salinas, 2005). Consistent with this
framework, anterior localization of Wnt antagonists such asDKK1
is required for anterior neural tube development (reviewed in
Glinka et al., 1998;Mukhopadhyay et al., 2001;Mudher et al., 2004;
Ciani and Salinas, 2005). At later stages, Wnt signaling further
patterns the neural tube by establishing signaling centers such as
the midbrain–hindbrain boundary, and restricting rhombomere
boundaries in the developing hindbrain (reviewed in McMahon
and Bradley, 1990; Thomas and Capecchi, 1990; Kim et al., 2000;
Lekven et al., 2001; Kapsimali et al., 2004; Ciani and Salinas, 2005).
Wnt signaling is also essential for dorsal/ventral patterning of
the neural tube. Several Wnts including Wnt1 and Wnt3a are
expressed in the dorsal neural tube and combined deletion of
Wnt1 and Wnt3a results in expansion of ventral cell fates at the
expense of dorsal fates (Megason and McMahon, 2002;Muroyama
et al., 2002). Overexpression of Wnt1 or Wnt3a causes expansion
of dorsal cell fates (Dickinson et al., 1994; Muroyama et al., 2002).
Wnts also promote dorsal and suppress ventral cell fates in the
telencephalon and are essential for the speciﬁcation of neural crest
(reviewed in Saint-Jeannet et al., 1997; Wu et al., 2003; Ciani and
Salinas, 2005).
PROLIFERATION
Wnt signaling also regulates proliferation of neural precursor cells
throughout CNS development. In the developing chick neural
tube, overexpression of Wnt1, Wnt3a, or stabilized β-catenin
increases neural precursor proliferation while expression of domi-
nant negative TCF4 (dnTCF4) reduces cell proliferation (Megason
and McMahon, 2002). In mice, Wnt1 overexpression increases
proliferation and neuronal cell size in the caudal midbrain leading
to signiﬁcant midbrain overgrowth (Panhuysen et al., 2004). Fur-
thermore, β-catenin loss of function in the diencephalon, mesen-
cephalon, and hindbrain diminishes progenitor cell domains and
decreases midbrain size, while β-catenin gain of function expands
progenitor cell domains and increases midbrain size (Zechner
et al., 2003). Wnts also regulate proliferation in the developing
hippocampus.Wnt3a loss of function reduces hippocampal neural
progenitor proliferation and disrupts hippocampal development
(Lee et al., 2000). Similar defects are observed when β-catenin is
deleted from the dorsal telencephalon (Machon et al., 2003). These
data suggest Wnt/β-catenin signaling promotes progenitor prolif-
eration in the developing neural tube as well as the midbrain and
hippocampus.
Deletion of both Gsk3a and Gsk3b from mouse neural prog-
enitors activates Wnt signaling and causes dramatic hyperprolif-
eration of Sox2-positive early neural progenitors (known as radial
progenitors) and increases proliferation as measured by the num-
ber of phospho-HistoneH3,BrdU, andKi67 positive cells,without
affecting apoptosis. Gsk3 deletion also reduces differentiation into
intermediate neural progenitors and postmitotic neurons. Dele-
tion of Gsk3a or Gsk3b alone does not signiﬁcantly affect brain
development demonstrating mostly redundant functions for the
two isoforms. Expression of a dominant negative TCF to block
downstream Wnt signaling in neural precursors cultured from
Gsk3a/b double mutant mice partially reduces cell proliferation,
suggesting that Gsk3 loss of function increases neural precursor
proliferation in part by activatingWnt signaling (Kim et al., 2009).
In support of this conclusion, expression of stabilized β-catenin
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in neural precursors also increases precursor proliferation (Chenn
and Walsh, 2002), and in utero electroporation of dnTCF reduces
cell proliferation (Woodhead et al., 2006). Taken together, these
data suggest a role for canonicalWnt signaling inpromotingneural
precursor proliferation in the embryo.
NEURAL MORPHOLOGY
In addition to regulating patterning and cell proliferation, Wnts
promote neurite outgrowth and inﬂuence axon size and branch-
ing, as well as growth cone size, complexity, and remodeling (Purro
et al., 2008).Wnt7a increases neurite, axon,and growth cone size in
cultured cerebellar granular cells and the Wnt antagonist secreted
frizzled related protein (sFRP)-1 reduces growth cone size and
prevents axon remodeling (Lucas and Salinas, 1997; Hall et al.,
2000). GSK-3 inhibitors also increase neurite size, promote neu-
rite outgrowth and axon formation, and increase axon size and
branching in many cell types, including cerebellar granular cells,
dorsal root ganglion neurons, and hippocampal neurons (Lucas
and Salinas, 1997; Hall et al., 2000; Gartner et al., 2006; Dill
et al., 2008). Wnts can also act as attractants to regulate commis-
sural axon guidance after crossing the midline in the developing
spinal cord; however, this activity is dependent on PI3K and atyp-
ical protein kinase C (aPKC) but not on LRP6, suggesting it is
not through the canonical Wnt/β-catenin pathway (Lyuksyutova
et al., 2003; Wolf et al., 2008). Wnts and β-catenin also promote
dendrite growth and branching and promote synapse formation
and plasticity (reviewed in Yu and Malenka, 2003; Rosso et al.,
2005; Budnik and Salinas, 2011). Wnt7a increases the number of
excitatory synapses in the hippocampus and promotes synapse
formation in the cerebellum (Hall et al., 2000; Ciani et al., 2011).
Neurodevelopmental phenotypes in mice containing Wnt
pathway mutations are summarized in Table 1.
CANONICAL Wnt SIGNALING IN ADULT NEUROGENESIS
Neurogenesis, the generation of new neurons, is a dynamic process
that involves proliferation and differentiation of neural progeni-
tors to produce new neurons which can then migrate,mature, and
integrate into neuronal circuitry. Neurogenesis was once thought
to occur during development only, but has since been observed
throughout the lifespan of adult mammals including humans
(Eriksson et al., 1998; reviewed in Suh et al., 2009; Ming and Song,
2011). In adult mammals, neurogenesis occurs in the subgranular
zone (SGZ) of the dentate gyrus within the hippocampus and in
the subventricular (SVG) zone adjacent to the lateral ventricles
in the forebrain. Neurons generated in the SGZ migrate into the
granular layer of thedentate gyruswhere theymature and integrate
into the existing neuronal circuitry and eventually behave similar
to their older neighbors. Neurons arising in the SVZ migrate ante-
riorly through the rostral migratory stream and differentiate into
interneurons in the olfactory bulb (reviewed in Gage, 2000; Lledo
et al., 2006; Ming and Song, 2011; Mongiat and Schinder, 2011).
Although deﬁnitive evidence of a functional role for adult
neurogenesis is limited, work from many groups suggests adult
neurogenesis may be important for learning, memory, and a sub-
set of behavioral responses to antidepressant medications in adult
mammals. Spatial and object recognitionmemory, stress response,
and contextual fear conditioning are among the behaviors that
Table 1 |Wnt pathway components are essential for neural
development.
Mutated genes Phenotype Reference
Wnt1 Absence of midbrain,
cerebellum
McMahon and Bradley
(1990), Thomas and
Capecchi (1990)
Wnt3 Reduced hippocampal
neurogenesis
Lie et al. (2005)
Wnt3a Absence of hippocampus Lee et al. (2000)
Wnt1/Wnt3a
double
mutant
Loss of dorsal interneurons in
the neural tube and expansion
of ventral interneuron fates
Muroyama et al. (2002)
Wnt7a Reduced hippocampal
neurogenesis, delayed
cerebellar synapse maturation
Hall et al. (2000)
Fzd3/Fzd6
double
mutant
Midbrain morphogenesis
defects
Stuebner et al. (2010)
Fzd4 Progressive loss of cerebellar
granule and Purkinje cells
Wang et al. (2001)
Fzd5 Decreased number of
neurons in the parafascicular
nucleus
Liu et al. (2008)
Axin Axis duplication Zeng et al. (1997)
Apc Embryonic lethality prior to
gastrulation
Moser et al. (1995)
*Gsk3a/b
double
mutant
Hyperproliferation of neural
progenitors
Kim et al. (2009)
Lrp6 Midbrain and cerebellar
malformations
Pinson et al. (2000)
Dkk1 Absence of anterior head
structures
Mukhopadhyay et al.
(2001)
b-catenin Defects in anterior/posterior
axis formation
Huelsken et al. (2000)
Lef1 Loss of granule cells of
dentate gyrus
Galceran et al. (2000)
Neurodevelopmental phenotypes are summarized in mice carrying loss of
function mutations in the indicated genes. *Gsk3a/b indicates conditional
deletion from neural progenitor cells. For more information please see Kim
and Snider (2011) in this volume and also visit The Wnt Homepage at
http://www.stanford.edu/group/nusselab/cgi-bin/wnt/
neurogenesis has been proposed to inﬂuence. Hippocampal irra-
diation inhibits neurogenesis and impairs spatial learning, contex-
tual fear conditioning, and behavioral and hormonal responses to
stress (Snyder et al., 2005, 2011). Importantly, similar results have
been observed using alternative methods to block hippocampal
neurogenesis (Saxe et al., 2006; Jessberger et al., 2009). Adult neu-
rogenesis in both the SGZ and SVZ has also been proposed to play
roles in pattern separation and/or memory resolution (Clelland
et al., 2009; reviewed in Aimone et al., 2011; Sahay et al., 2011).
SVG neurogenesis may also contribute to olfaction (reviewed in
Lazarini and Lledo, 2011). Interestingly new neurons in adult
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mammals exhibit unique properties at various stages of their mat-
uration, including hyperexcitability, enhanced synaptic plasticity,
and unique response to GABA, suggesting they may be able to
carry out unique functions in the adult brain (reviewed in Ge
et al., 2008; Deng et al., 2010). Thus, adult neurogenesis appears to
be an important regulator of learning, memory, and other behav-
iors, although behavioral data from some groups challenges these
conclusions, perhaps due to differing experimental conditions
(reviewed in Deng et al., 2010). A better understanding of the reg-
ulation of neural stem and progenitor cell homeostasis will also
likely contribute to the treatment of neurodegenerative disorders.
Thus, considerable recent attention has focused on the signaling
pathways and local factors that control adult neurogenesis.
Much of this attention has focused on the critical role for Wnt
signaling in adult neurogenesis. Several Wnt ligands including
Wnt3 and Wnt7a are expressed in adult hippocampal progenitors
(AHPs) and astrocytes near the SGZ (Lie et al., 2005; Wexler et al.,
2009). Adult mice lacking Wnt7a show reduced BrdU labeling in
the dentate gyrus and expression of dominant negative Wnt in the
dentate gyrus also decreases BrdU incorporation and decreases
the number of cells expressing Doublecortin (DCX), which marks
neuroblasts and newborn neurons (Lie et al., 2005;Qu et al., 2010).
Similarly, deletion and shRNA mediated knockdown of β-catenin
reduces the number of cells expressing neuronal markers in the
adult dentate gyrus (Kuwabara et al., 2009). Conversely, overex-
pression of Wnt3 in the dentate gyrus increases the number of
BrdU, DCX double positive cells (Lie et al., 2005). These data sug-
gest Wnt signaling promotes proliferation of neural progenitor
cells and hippocampal neurogenesis in vivo.
Additional support for the role of the Wnt pathway in neuro-
genesis comes from experiments with cultured AHPs. The Wnt
pathway is active under basal conditions in cultured AHPs and is
further activated by co-culture with adult hippocampal astrocytes
(Lie et al., 2005; Wexler et al., 2009). Treatment with Wnt antag-
onists, including the Frizzled extracellular domain and sFRPs,
reducesAHPproliferation and the number of cells expressing neu-
ronalmarkers. Similarly,overexpressionofAxin,GSK-3,dominant
negative TCF (dnTCF), or a truncated N-cadherin that binds and
sequesters β-catenin blocksWnt signaling and results in long term
depletion of multipotent AHPs and reduction of neuronal marker
expression (Lie et al., 2005;Wexler et al., 2008, 2009). Furthermore,
activatingWnt signaling in culturedAHPsby expressingWnt3, sta-
bilized β-catenin, a kinase dead GSK-3 mutant, or by adding the
GSK-3 inhibitor lithium, increasesAHPproliferation,BrdU incor-
poration, and neuronal marker expression (Lie et al., 2005;Wexler
et al., 2008). Lithium-inducedBrdUuptake is blocked by β-catenin
knockdown, further suggesting lithium inducesAHP proliferation
by activating Wnt signaling (Wexler et al., 2008). Taken together,
these data suggest Wnt/β-catenin signaling promotes progenitor
proliferation and neurogenesis both in culture and in vivo.
The disrupted in schizophrenia 1 (DISC1) gene is mutated
in affected family members in a Scottish pedigree with a high
incidence of schizophrenia and depression (Millar et al., 2000).
Although this familial syndrome and corresponding mutation are
extremely rare, investigation of DISC1 function has been highly
informative, as DISC1 protein was recently shown to bind and
inhibit GSK-3 (Mao et al., 2009). DISC1 knockdown increases
phosphorylation of β-catenin at the GSK-3 phosphorylation sites,
reduces total β-catenin levels, and reducesWnt reporter activation
and Wnt target gene expression, consistent with the proposed role
for DISC1 as an endogenous GSK-3 inhibitor. DISC1 knockdown
also reduces proliferation of AHPs in culture and in vivo, and this
effect is rescued by treatment with a GSK-3 inhibitor (Mao et al.,
2009). These data suggest DISC1 promotes proliferation in the
adult hippocampus by inhibiting GSK-3.
Several studies suggest Wnt signaling promotes progenitor
proliferation and neurogenesis in the adult SVZ as well as in hip-
pocampus. Expression of the Wnt antagonist DKK1 in the adult
mouse SVZ reduces neural progenitor cell proliferation, and inhi-
bition of GSK-3 or expression of stabilized β-catenin increases
progenitor cell proliferation. Inhibition of GSK-3 also increases
the number of new neurons in the olfactory bulb (Adachi et al.,
2007). Adult mice lacking Wnt7a show reduced BrdU labeling in
the subventricular zone, and overexpression of Axin in the SVZ of
wild type mice also reduces BrdU incorporation (Qu et al., 2010).
In cultured neural progenitor cells isolated from the SVZ, exposure
to Wnt3a, Wnt7a, or expression of stabilized β-catenin promotes
proliferation and neurogenesis (Yu et al., 2006; Qu et al., 2010).
Evidence that Wnt signaling is essential for adult neurogen-
esis has led to investigation of upstream factors that may pro-
mote neurogenesis by activating Wnt signaling and downstream
effectors that may mediate the effects of Wnt signaling on neu-
rogenesis. Recent evidence suggests the orphan nuclear receptor
TLX and hypoxia inducible factor-1 (HIF-1) regulate neurogene-
sis upstream of Wnt/β-catenin signaling. TLX is expressed in adult
neural stem cells in the dentate gyrus and the SVZ (Shi et al., 2004).
TLX binds to the Wnt7a promoter in adult neural stem cells and
promotesWnt7a transcription,β-catenin stabilization, and activa-
tion of Wnt target genes. Furthermore, TLX knockdown reduces
NSC proliferation, and this effect is blocked by Wnt7a treatment
or expression of stabilized β-catenin. In vivo, TLX null mice show
reduced BrdU labeling in the SVZ, and this is rescued by expres-
sion of stabilized β-catenin (Qu et al., 2010). These data suggest
TLX promotes adult neurogenesis by activating Wnt/β-catenin
signaling.
Similarly, HIF-1 promotes Wnt signaling and neurogenesis
(Mazumdar et al., 2010). HIF-1 is heterodimer of HIF-1α and
HIF-1β/ARNT that regulates the response to hypoxia. Knockout of
Hif1a,which encodes theHIF-1α subunit, reducesWnt target gene
expression in the adult hippocampus.Hif1a knockout also reduces
BrdU incorporation and the number of newborn DCX positive
neurons in the hippocampus. These effects are rescued by inhibi-
tion of GSK-3 and by expression of stabilized β-catenin, suggesting
that HIF-1 functions upstream of the Wnt pathway to promote
neurogenesis (Mazumdar et al., 2010). Interestingly, AHPs occupy
a hypoxic niche in vivo, and hypoxia dramatically increases TLX
protein levels in cultured AHPs (Mazumdar et al., 2010; Chavali
et al., 2011). Furthermore, TLX knockdown under hypoxic condi-
tions reduces AHP proliferation, suggesting TLX promotes neural
stem or progenitor cell proliferation under hypoxic conditions
(Chavali et al., 2011). These data suggest a potential link between
HIF-1 and TLX functions upstream of Wnt signaling.
Downstream of Wnt signaling, NeuroD1 and the prospero-
related homeodomain transcription factor Prox1 represent two
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intriguing candidates for Wnt target genes that may mediate the
effects of Wnt signaling on neurogenesis. The NeuroD1 promoter
contains several LEF/TCF binding sites and activating Wnt signal-
ing by addition of either Wnt3a or the GSK-3 inhibitor TDZD8
increases NeuroD1 mRNA expression in cultured adult rat hip-
pocampal NSCs, while blocking Wnt signaling with DKK1, domi-
nant negative Wnt or β-catenin shRNA reduces NeuroD1 mRNA.
Wnt3a treatment increases the number of cells expressing neu-
ronal markers in cultured adult hippocampal NSCs, and in neu-
rospheres cultured from adult mice, and this effect is blocked by
NeuroD1 loss of function (Kuwabara et al., 2009). Overexpression
of NeuroD in cultured adult hippocampal NSCs increases neu-
ronal marker expression, mimicking the effect of Wnt3a (Hsieh
et al., 2004). In the adult SGZ, NeuroD1 is expressed in neural
progenitors and neuroblasts, including Ki67, and BrdU positive
cells (Gao et al., 2009; Kuwabara et al., 2009). NeuroD1 deletion
mimics Wnt loss of function by reducing the number of newborn
neurons in the adult dentate gyrus as well as in the olfactory bulb,
while NeuroD1 overexpression in the forebrain induces neuroge-
nesis in the SVZ and rostral migratory stream (Gao et al., 2009;
Boutin et al., 2010). These data suggestWnt signalingmaypromote
neurogenesis by inducing NeuroD1 expression.
Prox1 may also mediate the effects of Wnts on neurogene-
sis. β-Catenin associates with LEF/TCF binding sites in the Prox1
enhancer and promotes Prox1 expression in adult hippocampal
NSCs. Prox1 is expressed in neural progenitors and both immature
andmatureneurons in the adult dentate gyrus. Expressionof dom-
inant negative LEF (dnLEF) in the dentate gyrus reduces Prox1
expression and expression of stabilized β-catenin induces Prox1
expression. Prox1 knockdown in the dentate gyrus reduces the
number of newborn neurons and Prox1 overexpression increases
the number of newborn neurons (Karalay et al., 2011). These data
suggest Prox1 is a direct Wnt target that promotes neurogenesis.
Importantly, further investigation is necessary to determine in vivo
whether NeuroD1 or Prox1 expression can rescue neurogenesis
defects resulting from Wnt pathway inhibition or whether Wnt-
induced neurogenesis can be blocked by NeuroD1 or Prox1 loss of
function.
LITHIUM ACTION IN BIPOLAR DISORDER
Bipolar disorder is a common neuropsychiatric disorder charac-
terized by episodes of mania anddepression, affecting an estimated
50–100 million people world-wide, and is associated with sig-
niﬁcant morbidity and mortality (reviewed in Belmaker, 2004;
Goodwin and Jamison, 2007; Chen et al., 2010). Lithium has been
widely used to treat BPD for over half a century, but its mechanism
of action is not fully understood. Lithium also has a narrow ther-
apeutic index and therapy is associated with multiple side effects,
including thyroid dysfunction, nephrogenic diabetes insipidus,
weight gain, arrhythmias, leukocytosis, tremor, and a variety of
CNS and neuromuscular side effects (reviewed in Gilman, 1996).
Thus, deﬁning the molecular and cellular mechanisms of lithium
action may provide insights into the pathogenesis of BPD and also
lead to the development of better treatments for this common and
devastating disorder.
An animalmodel of BPDwould be extremely valuable in testing
pathogenic and therapeutic mechanisms, but accurately assessing
affect or affective disorders, especially with the added complexity
of cycling of mood, in amodel organism amendable to experimen-
tal manipulation is inherently challenging. Thus we and others
have turned to animal behaviors that are inﬂuenced by mood sta-
bilizers, including lithium, and can be measured in an objective
and reproducible manner. Until recently, surprisingly few behav-
iors had been described that are sensitive to chronic lithium,
most notably the amphetamine-induced hyperactivity behavior
(reviewed in Murphy, 1977; Crawley, 2000). We have found that
the forced swim test, classically used to assess antidepressant effects
in rodents, is robustly sensitive to chronic lithium, with marked
decrease in immobility in lithium treated mice (O’Brien et al.,
2004). In addition, chronic lithium affects behavior in the ele-
vated zero maze, a test often used to assess anxiolytic efﬁcacy, and
exploratory behavior (O’Brien et al., 2004; reviewed in O’Brien
and Klein, 2009). Beaulieu et al. (2008) have shown that lithium
also affects the tail suspension test and light–dark emergence, and
Thakker-Varia et al. (2010) showed that lithium affects the novelty
suppressed feeding paradigm.
LITHIUM REGULATES MAMMALIAN BEHAVIORS BY INHIBITING GSK-3
Numerous hypotheses have been put forth to explain the mech-
anisms of lithium action in mammalian behavior and in BPD
(reviewed in Gurvich and Klein, 2002), but the number of direct
lithium targets is quite limited. These include GSK-3 (Klein and
Melton, 1996), inositol monophosphatase (IMPase) and struc-
turally related enzymes (reviewed in Berridge et al., 1989; York
et al., 2001; Gurvich and Klein, 2002), phosphoglucomutase
(reviewed in Gurvich and Klein, 2002), and a β-arrestin-2 com-
plex that regulates response to dopamine in the striatum (Beaulieu
et al., 2008). Given the multiple plausible targets of lithium, we
have suggested that validation of a proposed target of lithium
should include evidence that (1) lithium inhibits the target at
therapeutically relevant concentrations in vitro and in vivo, (2)
structurally distinct inhibitors of the target should mimic lithium,
(3) genetic loss of function of the target should alsomimic lithium,
and (4) the effects of lithium should be reversed by restoring func-
tion of the target (reviewed in Phiel and Klein, 2001; O’Brien and
Klein, 2009).
Evidence from invertebrates suggests lithium can regulate
behavior by inhibiting inositol phosphatases. In the nematode
Caenorhabditis elegans,mutation of the inositolmonophosphatase
TTX-7 disrupts thermotaxis, and this behavioral phenotype is
mimicked by lithium treatment; lithium also causes synaptic
defects that phenocopy the ttx-7 mutant and both behavior and
synaptic defects are prevented by inositol treatment or by TTX-
7 overexpression (Tanizawa et al., 2006). These ﬁndings strongly
support a role for inositol depletion in the effect of lithium on
thermotaxis in C. elegans. Mutation of inositol polyphosphate
1-phosphatase (IPP) in Drosophila causes defects in synaptic
vesicle release that are phenocopied by lithium (Acharya et al.,
1998), although it is not known whether lithium or loss of IPP
affects myo-inositol levels in this setting. However, inositol deple-
tion in mammals does not mimic lithium effects on behavior;
heterozygous deletion of the sodium dependent myo-inositol
cotransporter-1 (SMIT1) in mice reduces brain myo-inositol lev-
els to a similar or greater degree than lithium, but has no effect
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on behavioral phenotypes that are robustly affected by lithium
(Shaldubina et al., 2006). These data suggest that global inositol
depletion is not responsible for the behavioral effects of lithium in
mammals.
We have proposed that the behavioral effects of lithium in
mammals are mediated through inhibition of GSK-3 (O’Brien
et al., 2004). GSK-3 fulﬁlls each of the validation criteria described
above: Lithium inhibits GSK-3 both in vitro and in vivo at thera-
peutically relevant concentrations (Klein and Melton, 1996; Stam-
bolic et al., 1996; Hedgepeth et al., 1997; Hong et al., 1997;Munoz-
Montano et al., 1997;Mudher et al., 2004;O’Brien et al., 2004), and
structurally distinct GSK-3 inhibitors mimic the effects of lithium
on mouse behaviors such as the forced swim test, exploratory
behavior (Kaidanovich-Beilin et al., 2004; Pan et al., 2011;
reviewed in O’Brien and Klein, 2009), light/dark emergence, and
amphetamine-induced hyperactivity (Gould et al., 2004; Beaulieu
et al., 2008). Furthermore, heterozygous loss of Gsk3b mimics
lithium action inmultiple behaviors (Beaulieu et al., 2004;O’Brien
et al., 2004) and homozygous deletion of Gsk3a was also recently
shown to mimic the behavioral effects of lithium and other GSK-
3 inhibitors (Table 2; Kaidanovich-Beilin et al., 2009). Impor-
tantly, Gsk3b overexpression blocks the behavioral effects of LiCl
(O’Brien et al., 2011). Taken together, these data strongly support
GSK-3 as the relevant target of lithium in mammalian behavior.
In an elegant series of experiments, Beaulieu, Caron, and col-
leagues showed that, in the striatum, β-arrestin-2 forms a scaffold
that binds Akt and protein phosphatase-2 (PP2A). Within this
scaffold, PP2A dephosphorylates and deactivates Akt, preventing
Akt-mediatedphosphorylation and inhibitionof GSK-3.They also
showed that lithium disrupts this complex and proposed that this
leads to Akt-mediated inhibition of GSK-3 (Beaulieu et al., 2008).
Their ﬁndings therefore suggested that lithium inhibits GSK-3
indirectly.
However, these data are also compatible with direct inhibition
of GSK-3 by lithium. We recently showed that GSK-3, which also
binds to β-arrestin-2, maintains the stability of the β-arrestin-2
complex and lithium disrupts the complex by directly inhibiting
GSK-3 (Figure 2; Beaulieu et al., 2005; O’Brien et al., 2011). In
support of this mechanism, structurally distinct GSK-3 inhibitors
aswell as heterozygous loss of Gsk3b disrupt the complex and over-
expression of Gsk3b restores basal levels of complex in the presence
FIGURE 2 | Glycogen synthase kinase-3 regulation of the β-arrestin-2
scaffold. GSK-3 binds to and stabilizes the β-arrestin-2/PP2A/Akt complex,
promoting PP2A-mediated dephosphorylation, and inactivation of Akt,
which in turn maintains GSK-3 in an active state. Direct inhibition of GSK-3
disrupts the β-arrestin-2/PP2A/Akt interaction allowing activation of Akt,
which then phosphorylates, and inhibits GSK-3.
of lithium (O’Brien et al., 2011). These data suggest that GSK-3
stabilizes the β-arrestin-2 complex and that lithium disrupts the
complex by inhibiting GSK-3.
Thus, the hypothesis that lithium modulates behaviors through
direct inhibition of GSK-3 is strongly supported by each of the val-
idation criteria described above, and while the data do not rule out
contributions from other proposed targets, they provide a com-
pelling rationale for pursuing GSK-3 substrates and downstream
signaling pathways that mediate the behavioral and therapeutic
effects of lithium.
POSITIVE FEEDBACK REGULATION OF GSK-3
These observations demonstrate both direct and indirect mech-
anisms of GSK-3 inhibition by lithium and imply a positive
feedback system in which GSK-3 maintains its own activity by
stabilizing the β-arrestin-2 complex, leading to dephosphoryla-
tion and inhibition of Akt (Figure 2). As Akt inhibits GSK-3,
stabilization of the β-arrestin-2 complex by GSK-3 antagonizes
this inhibition. In this model, a direct GSK-3 inhibitor is pre-
dicted to lead to indirect inhibition through enhanced N-terminal
phosphorylation of GSK-3, as has been observed in many in vivo
and cell culture contexts. This model can also explain how lithium
activates Akt, as observed previously (Chalecka-Franaszek and
Chuang, 1999). Through a parallel positive feedback circuit, GSK-
3 regulates protein phosphatase 1 (PP1) and the PP1 inhibitor I-2
(Zhang et al., 2003). PP1 dephosphorylates and activates GSK-3;
I-2 inhibits this reaction but I-2 in turn is deactivated by GSK-3;
hence GSK-3 enhances its own activity by activating PP1. Taken
together, these positive feedback systems provide discrete mecha-
nisms to explain tissue-speciﬁc enhancement of GSK-3 inhibition
by lithium (Figure 3), and may also help to explain why lithium
is effective, both clinically and in mouse behaviors, at 1mM, close
to its in vitro IC50 (O’Brien et al., 2004).
POTENTIAL MECHANISMS MEDIATING BEHAVIORAL EFFECTS OF
GSK-3 INHIBITION
Since GSK-3 has emerged as the likely target of lithium in mam-
malian behavior, much attention has focused on mechanisms
FIGURE 3 | Positive feedback regulation of GSK-3 through β-arrestin-2
and PP1. GSK-3 regulates its own activity by modulating its N-terminal
phosphorylation state. As shown in Figure 2, GSK-3 enhances stability of
the β-arrestin-2 scaffold, leading to inactivation of Akt, and thereby reducing
GSK-3 phosphorylation. In addition, PP1 dephosphorylates and activates
GSK-3, but is inhibited by the PP1-speciﬁc inhibitor-2 (I-2). GSK-3 inactivates
I-2, preventing PP1 inhibition, and thereby maintaining dephosphorylation
of GSK-3. Thus GSK-3 activity is regulated by positive feedback loops
involving β-arrestin-2 and PP1.
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downstream of GSK-3 that may contribute to lithium effects.
GSK-3 regulates dozens of substrates directly, regulates multiple
signaling pathways including Wnt and Akt-dependent signaling,
and controls cellular processes such as neurogenesis and survival
(Doble et al., 2007). Lithium promotes adult hippocampal neuro-
genesis and several groups have proposed that this is an essential
function of mood stabilizers (Chen et al., 1999; Son et al., 2003;
Silva et al., 2008; Fiorentini et al., 2010; Hanson et al., 2011;
reviewed in Samuels andHen, 2011). In this regard, there are inter-
esting parallels between the effects of mood stabilizing drugs and
antidepressants in rodents: Structurally diverse antidepressants
also stimulate neurogenesis (Malberg et al., 2000; Santarelli et al.,
2003), have similar effects as chronic lithium in multiple behaviors
(Table 2), and stimulateN-terminal inhibitory phosphorylation of
GSK-3 (Li et al., 2004; reviewed in Polter and Li, 2010), suggest-
ing that they may act through similar mechanisms. Hippocampal
irradiation blocks the effects of antidepressants in the chronic
unpredictable stress and novelty suppressed feeding paradigms
suggesting hippocampal neurogenesis is required for the behav-
ioral effects of antidepressants (Santarelli et al., 2003). By analogy,
enhancing neurogenesis may be critical for the mood stabilizing
effects of lithium. Although the requirement for neurogenesis in
the behavioral response to lithium has not been tested, it would be
intriguing and somewhat surprising to ﬁnd that antimanic agents
and antidepressants act through similar mechanisms.
Lithium inhibits GSK-3 to activate canonical Wnt signaling
which promotes adult neurogenesis; thus chronic lithium may
inﬂuence behavior by stimulating Wnt-dependent neurogenesis.
In support of this proposed mechanism, chronic lithium activates
Wnt signaling in the dentate gyrus in mice and expression of
an activated form of β-catenin reduces immobility in the forced
swim test (Gould et al., 2007). However, whether Wnt signaling is
required for behavioral responses to lithiumhas not been explicitly
tested. In addition, the requirement for Wnt-induced neurogene-
sis in behavior has not been studied. Lithium also activates Wnt
signaling in the amygdala and hypothalamus, areas not known
to support adult neurogenesis (O’Brien et al., 2004). Thus, Wnt
target genes could function independently of neurogenesis to reg-
ulate lithium-sensitive behaviors. Importantly, lithium effects on
non-neuronal cell types may also be important for its effects on
behavior.
Glycogen synthase kinase-3 negatively regulates cell survival
pathways suggesting additional mechanisms by which lithium
could promote neurogenesis. Growth factors such as insulin, EGF,
andneurotrophins activateAkt,whichphosphorylates and inhibits
GSK-3 to promote cell survival and proliferation (reviewed in
Wada, 2009). In addition to inhibiting GSK-3 directly, lithium
increases brain-derived neurotrophic factor (BDNF) levels (Fuku-
moto et al., 2001), and stimulatesAkt andAkt-mediated inhibitory
phosphorylation of GSK-3 (at Ser9/21) in the striatum (Beaulieu
et al., 2008; Pan et al., 2011). Inhibitory GSK-3 phosphorylation
may be important for the behavioral effects of lithium as Akt
inhibition blocks the effects of lithium on amphetamine-induced
hyperlocomotion (Pan et al., 2011), and Ser9/21 to alanine muta-
tions have the opposite effects as lithium in somebehaviors includ-
ing increased exploratory behavior and increased amphetamine-
induced hyperactivity (Ackermann et al., 2010; Polter et al., 2010).
Ser9/21 to alanine mutations also reduce BrdU incorporation in
the adult dentate gyrus and block stimulation of neurogenesis by
co-treatment with lithium and ﬂuoxetine (Eom and Jope, 2009a),
suggesting GSK-3 phosphorylation promotes adult hippocampal
neurogenesis and may be required for the effects of lithium and
antidepressants on neurogenesis and behavior.
Interestingly, Akt may also enhance canonical Wnt pathway
activation by lithium. As discussed above, lithium can activate Akt
indirectly. Furthermore, lithium-induced Wnt reporter activation
is attenuated by inhibition of Akt or PI3K, as well as by overexpres-
sion of the Akt inhibitor phosphatase and tensin homolog (PTEN;
Pan et al., 2011). As N-terminal phosphorylation of GSK-3 does
not promote Wnt signaling (Ding et al., 2000; McManus et al.,
Table 2 | Parallels between GSK-3 inhibitors and antidepressants in adult neurogenesis and behavior.
Phenotype Lithium Alternative GSK-3 inhibitors GSK-3 deletion Antidepressants
Adult neurogenesis ↑ ↑ (SB216763) ↑ (Fluoxetine, tranyl-
cypromine, reboxetine)
Forced swim test (immobility) ↓ ↓ (CHIR99021, AR-A014418,
L803mts)
↓ (Gsk3b+/− or Gsk3a−/−) ↓ (Fluoxetine, desipramine)
Exploratory behavior (hole pokes) ↓ ↓ (Gsk3b+/−)
Elevated zero/plus maze (time in open area) ↑ ↑ (Gsk3b+/−) ↑ (Citalopram)
Tail suspension test (immobility) ↓ ↓ (Gsk3a−/−) ↓ (Citalopram)
Novelty suppressed feeding ↓ ↓ (Fluoxetine, imipramine,
desipramine)
Novelty induced locomotor activity ↓ ↓ (TDZD-8) ↓ (Gsk3a−/−)
Amphetamine induced hyperlocomotion ↓ ↓ (CHIR99021, TDZD-8, 6-BIO,
AR-A014418, SB216763,
alsterpaullone)
↓ (Gsk3b+/−)
Lithium stimulates adult neurogenesis and affects mammalian behaviors. Structurally diverse GSK-3 inhibitors as well as genetic loss of GSK-3 function mimic the
effects of lithium, strongly implicating GSK-3 as the relevant target mediating lithium effects on behavior. Interestingly, distinct classes of antidepressants have similar
effects as lithium on neurogenesis and many behaviors.
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2005), Akt may either phosphorylate GSK-3 at other sites or regu-
late other components of the Wnt pathway. So far, alternative Akt
phosphorylation sites in GSK-3 have not been described. How-
ever, Akt can phosphorylate β-catenin directly at a C-terminal site
(Ser552), distinct from the GSK-3 phosphorylation sites, promot-
ing β-catenin cytoplasmic and nuclear localization while reducing
membrane localization (Fang et al., 2007).While speculative, these
data raise the interesting possibility that Akt could contribute to
β-catenin signaling in the response to lithium or other GSK-3
inhibitors.
Lithium may also affect behavior by inhibiting GSK-3 in the
β-arrestin-2 complex in the striatum. β-Arrestin-2 prevents Akt-
mediated inhibition of GSK-3, as β-arrestin-2 knockout activates
Akt and increases inhibitory phosphorylation of GSK-3. Further-
more, β-arrestin-2 is required for effects of lithium on light/dark
emergence and time immobile in the tail suspension test, andmim-
ics the effect of lithium on novelty induced locomotor activity
(Beaulieu et al., 2008).
Akt-mediated GSK-3 phosphorylation promotes cell growth,
proliferation, and survival by activating downstreameffectors such
as mTOR, a key signaling complex that promotes protein transla-
tion and cell growth, regulates cell metabolism, and also regulates
stem cell fate decisions (Huang et al., 2009; Duvel et al., 2010; Sato
et al., 2010). GSK-3 negatively regulates mTOR by phosphorylat-
ing tuberous sclerosis complex-2 (TSC2), a core component of
TSC (Inoki et al., 2006). The TSC is a GTPase activating factor
that antagonizes the function of the small GTPase rheB, which is
required to activate mTOR in response to nutrients (Inoki et al.,
2003). Thus, inhibition of GSK-3 enhances rheB function and
leads to activation of mTOR. Activation of mTOR by lithium or
Gsk3 knockdown was demonstrated in cell culture and conﬁrmed
in vivo (Inoki et al., 2006; Huang et al., 2009). Interestingly,mTOR
is also regulated by the Axin–GSK-3 complex, and canonical Wnt
ligands activate mTOR in a β-catenin independent manner (Inoki
et al., 2006). These data suggest mTOR may contribute to effects
of Wnts, Akt, and lithium (Figure 4).
Hypoxia inducible factor-1 is another compelling candidate to
mediate the effects of lithium as it promotes hippocampal neuro-
genesis and is functionally integrated with Insulin/PI3K signaling,
Wnt signaling, GSK-3, and mTOR (Figure 4). GSK-3 phospho-
rylates HIF-1α resulting in proteasome-dependent HIF-1α degra-
dation, and inhibition of GSK-3 by lithium, Gsk3 knockdown,
or exposure to insulin increases HIF-1α protein levels (Flugel
et al., 2007). HIF-1α stabilization in response to hypoxia can
also be blocked by PI3K inhibition, which prevents inhibitory
phosphorylation of GSK-3 (Mottet et al., 2003; Schnitzer et al.,
2005).
Alternatively, GSK-3 may regulate HIF-1α abundance through
regulation of mTOR (Figure 4). As discussed above, inhibition of
GSK-3 activates mTOR, and mTOR activation increases HIF-1α
translation and activates HIF-1α target genes including vascular
endothelial growth factor (VEGF; Duvel et al., 2010). Fluoxe-
tine and desipramine increase VEGF levels in the hippocampus,
and inhibition of the VEGF receptor blocks the increase in neu-
rogenesis and the behavioral effects caused by these two anti-
depressants (Warner-Schmidt and Duman, 2007; Greene et al.,
2009). Increasing VEGF levels in the hippocampus is sufﬁcient
FIGURE 4 | Potential for crosstalk betweenWnt and Akt-dependent
signaling pathways through mTOR and HIF-1α.Wnt and Akt-dependent
signaling pathways activate mTOR and mTOR promotes HIF-1α translation.
ThusWnt-induced mTOR activation may enhance HIF-1α function
downstream of Akt. Furthermore HIF-1α promotesWnt target gene
expression by enhancing LEF/TCF transcription in embryonic and neural
stem cells, suggesting that HIF-1α activation downstream of Akt may
promoteWnt signaling. Interestingly, GSK-3 has also been shown to
contribute to HIF-1α degradation, and therefore inhibition of GSK-3 by either
small molecules or Akt-dependent pathways may also stabilize HIF-1α and
enhance HIF-1 signaling (Mottet et al., 2003; Schnitzer et al., 2005; Flugel
et al., 2007).
to stimulate neurogenesis, and has similar effects as lithium and
antidepressants on behavior (Warner-Schmidt and Duman, 2007;
Segi-Nishida et al., 2008;Udo et al., 2008). These data suggest HIF-
1 and its target VEGF may be important for the effects of lithium
onneurogenesis and behavior. Interestingly,HIF-1α also promotes
canonical Wnt signaling (Mazumdar et al., 2010). HIF-1α pro-
motes LEF-1 and TCF-1 transcription and antagonizes expression
of APC, a negative regulator of Wnt signaling (Mazumdar et al.,
2010; Newton et al., 2010). Thus HIF-1 may regulate neurogenesis
and behavior through multiple downstream effectors.
Much evidence suggests GSK-3 also promotes apoptosis in
many cell types, including neurons. Lithium blocks Bax and
caspase-3 activation in response to trophic factor withdrawal and
genotoxic stress in cultured neural precursor cells and protects
against apoptosis resulting from glutamate induced excitotoxic-
ity in multiple cell types (Nonaka et al., 1998; Eom et al., 2007).
Lithium also increases levels of anti-apoptotic B-cell lymphoma
protein-2 (bcl-2) in the hippocampus (Chen and Chuang, 1999;
Chen et al., 1999). Neuronal apoptosis induced by trophic fac-
tor withdrawal or PI3K inhibition can be blocked by structurally
diverse GSK-3 inhibitors, by an inhibitory GSK-3 binding protein
(GBP),or by dominant negativeGSK-3 (Hetman et al., 2000;Cross
et al., 2001). Lithium and other GSK-3 inhibitors also block neu-
ronal apoptosis induced by constitutively active c-Jun (Hongisto
et al., 2003). In addition, GSK-3 enhances p53 function through
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direct interactionwith p53 and through phosphorylation and acti-
vation of Tip60, an acetyltransferase required for p53-dependent
apoptosis (Watcharasit et al., 2003; Eom and Jope, 2009b; Charvet
et al., 2011). Thus, lithium and other GSK-3 inhibitors promote
survival in part by attenuating p53 levels and/or activity. Gsk3b
overexpression also induces apoptosis in cultured cortical neu-
rons (Pap and Cooper, 1998; Hetman et al., 2000). Taken together,
these data suggest GSK-3 promotes apoptosis and inhibiting
GSK-3 blocks apoptosis in response to diverse challenges. Thus
reduced apoptosis resulting fromGSK-3 inhibition by lithiummay
contribute to increased neurogenesis and effects on behavior.
CONCLUSION
Wnt signaling regulates many aspects of mammalian CNS devel-
opment and continues to play critical roles in the adult CNS,
including adult neurogenesis. Canonical Wnt signaling may also
play a key role in the therapeutic response to lithium in BPD,
as lithium activates the pathway by inhibiting GSK-3. In ani-
mal models, lithium regulates multiple mammalian behaviors by
inhibiting GSK-3. However, GSK-3 regulates multiple pathways in
addition to Wnt signaling,most notably Akt-dependent signaling,
and each of these pathways may contribute to neurogenesis, cell
proliferation, cell survival, and neuralmorphology. Thus, how dis-
tinct GSK-3 regulated pathways interact to mediate the effects of
lithium on neurogenesis and behavior has not yet been delineated.
Furthermore, the evidence that GSK-3 inhibition mediates the
therapeutic effects of lithium in patients with BPD is still limited.
Exciting recent work has shown that inhibitoryGSK-3 phosphory-
lation is reduced in peripheral blood mononuclear cells (PBMCs)
of patients with BPD compared to healthy controls suggesting
GSK-3 is aberrantly active in BPD patients (Polter et al., 2010). In
addition, lithiumand othermood stabilizers increaseGSK-3 phos-
phorylation (reviewed in Li and Jope, 2010) in PBMCs of BPD
patients. Thus, while the number of patients studied is still small,
the therapeutic effects of lithium in BPD may involve both direct
and indirect inhibition of GSK-3. Finally, an outstanding question
has been whether lithium is a sufﬁciently potent GSK-3 inhibitor
to explain its therapeutic action. Recent ﬁndings support several
positive feedback circuits that confer GSK-3 autoregulation and
these may enhance the sensitivity to lithium in a tissue-speciﬁc
manner. Better understanding of these intriguing complexities
will aid in the development of new therapeutics for patients with
BPD.
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